title: Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer.
abstract: alpha 1-acid glycoprotein (AGP) is a serum acute phase glycoprotein which possesses five N-linked complex type heteroglycan side chains which may be present as bi-, tri- and tetraantennary structures. Depending upon the content of biantennary structure on AGP, up to four glycoforms of AGP are present in serum. These glycoforms can be easily estimated in body fluids by means of crossed affinity-immunoelectrophoresis (CAIE) with the lectin, Concanavalin A (Con A). Con A selectively binds biantennary structures; the more biantennary structures on AGP, the stronger the binding. In acute inflammation, a relative increase of AGP glycoforms with biantennary units is observed-a type I glycosylation change. In some chronic inflammatory states there is an relative decrease of AGP glycoforms with biantennary heteroglycans-a type II glycosylation change. Moreover, in certain other states such as pregnancy, estrogen administration or liver damage, type II glycosylation changes are also seen. A detailed analysis of the clinical applications of the assessment of AGP glycoforms in sera of patients with rheumatic diseases, AIDS and various types of cancers is presented. Accumulated data shows that AGP glycoforms may be very useful in the detection of intercurrent infections in the course of rheumatoid arthritis, systemic lupus erythematosus, or myeloblastic leukaemia, and in the detection of secondary infections in human immunodeficiency virus infected individuals. AGP glycoforms are also very useful in differentiation between various forms of trophoblastic disease and are helpful in monitoring the treatment of these patients. Finally, AGP glycoforms provide valuable information for differentiation between primary and secondary liver cancer.
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000097:blood; D015415:Biomarkers / Q000737:chemistry; D014408:Biomarkers, Tumor / Q000097:blood*; D006801:Humans; D007249:Inflammation / Q000097:blood*; D009363:Neoplasm Proteins / Q000737:chemistry* / Q000378:metabolism; D009369:Neoplasms / Q000097:blood / Q000737:chemistry; D009961:Orosomucoid / Q000737:chemistry* / Q000378:metabolism; D012216:Rheumatic Diseases / Q000097:blood
chemical_list: D015415:Biomarkers; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D009961:Orosomucoid